Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bronstein

Showing results (121-130 of 164) with videos related to

Pageof 17
Sort By:
Clinics (Sao Paulo, Brazil)|June 20, 2013
PROP1 overexpression in corticotrophinomas: evidence for the role of PROP1 in the maintenance of cells committed to corticotrophic differentiationRicardo V Araujo, Claudia V Chang, Valter A S Cescato, et al.
BMC Endocrine Disorders|April 4, 2016
Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III studyMarcello D Bronstein, Maria Fleseriu, Sebastian Neggers, et al.
European Journal of Endocrinology|June 7, 2015
Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD studySebastian J C M M Neggers, Vyacheslav Pronin, Inga Balcere, et al.
Annales D'Endocrinologie|October 16, 2018
Association between KISS1 rs5780218 promoter polymorphism and onset of growth hormone secreting pituitary adenomaPaulo V G H Amorim, Isabella P P Grande, Rafael L Batista, et al.
The Journal of Clinical Endocrinology and Metabolism|April 19, 2021
Impaired Bone Microarchitecture in Premenopausal Women With Acromegaly: The Possible Role of Wnt SignalingPaula P B Silva, Rosa M R Pereira, Liliam Takayama, et al.
Pituitary|November 3, 2009
Management of acromegaly in Latin America: expert panel recommendationsAriel Barkan, Marcello D Bronstein, Oscar D Bruno, et al.
Journal of Endocrinological Investigation|July 2, 2016
Negative correlation between tumour size and cortisol/ACTH ratios in patients with Cushing's disease harbouring microadenomas or macroadenomasM C Machado, A E E Alcantara, A C L Pereira, et al.
The American Journal of Sports Medicine|July 18, 2023
Effect of Insurance Reimbursement Status on Pre- and Postoperative Patient-Reported Outcomes Measurement Information System (PROMIS) Scores After Arthroscopic Rotator Cuff RepairDevon E Anderson, Hashim J F Shaikh, Alexander R Chait, et al.
The American Journal of Sports Medicine|August 8, 2023
Use of Area Deprivation Index to Predict Minimal Clinically Important Difference for Patient Reported Outcomes Measurement Information System After Arthroscopic Rotator Cuff RepairHashim J F Shaikh, Devon E Anderson, Alexander R Chait, et al.
Endocrine Connections|January 12, 2021
Risk factors and management of pasireotide-associated hyperglycemia in acromegalyMônica R Gadelha, Feng Gu, Marcello D Bronstein, et al.
Pageof 17

Showing results (121-130 of 164) with videos related to

Sort By:
Pageof 17
Clinics (Sao Paulo, Brazil)|June 20, 2013
PROP1 overexpression in corticotrophinomas: evidence for the role of PROP1 in the maintenance of cells committed to corticotrophic differentiationRicardo V Araujo, Claudia V Chang, Valter A S Cescato, et al.
BMC Endocrine Disorders|April 4, 2016
Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III studyMarcello D Bronstein, Maria Fleseriu, Sebastian Neggers, et al.
European Journal of Endocrinology|June 7, 2015
Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD studySebastian J C M M Neggers, Vyacheslav Pronin, Inga Balcere, et al.
Annales D'Endocrinologie|October 16, 2018
Association between KISS1 rs5780218 promoter polymorphism and onset of growth hormone secreting pituitary adenomaPaulo V G H Amorim, Isabella P P Grande, Rafael L Batista, et al.
The Journal of Clinical Endocrinology and Metabolism|April 19, 2021
Impaired Bone Microarchitecture in Premenopausal Women With Acromegaly: The Possible Role of Wnt SignalingPaula P B Silva, Rosa M R Pereira, Liliam Takayama, et al.
Pituitary|November 3, 2009
Management of acromegaly in Latin America: expert panel recommendationsAriel Barkan, Marcello D Bronstein, Oscar D Bruno, et al.
Journal of Endocrinological Investigation|July 2, 2016
Negative correlation between tumour size and cortisol/ACTH ratios in patients with Cushing's disease harbouring microadenomas or macroadenomasM C Machado, A E E Alcantara, A C L Pereira, et al.
The American Journal of Sports Medicine|July 18, 2023
Effect of Insurance Reimbursement Status on Pre- and Postoperative Patient-Reported Outcomes Measurement Information System (PROMIS) Scores After Arthroscopic Rotator Cuff RepairDevon E Anderson, Hashim J F Shaikh, Alexander R Chait, et al.
The American Journal of Sports Medicine|August 8, 2023
Use of Area Deprivation Index to Predict Minimal Clinically Important Difference for Patient Reported Outcomes Measurement Information System After Arthroscopic Rotator Cuff RepairHashim J F Shaikh, Devon E Anderson, Alexander R Chait, et al.
Endocrine Connections|January 12, 2021
Risk factors and management of pasireotide-associated hyperglycemia in acromegalyMônica R Gadelha, Feng Gu, Marcello D Bronstein, et al.
Pageof 17